Goldman Sachs’s Direxion Daily Healthcare Bull 3X ETF CURE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.62M Buy
+41,158
New +$3.87M ﹤0.01% 3941
2023
Q4
Sell
-37,525
Closed -$3.32M 5658
2023
Q3
$3.32M Buy
37,525
+17,724
+90% +$1.74M ﹤0.01% 3351
2023
Q2
$1.98M Buy
19,801
+16,002
+421% +$1.59M ﹤0.01% 3883
2023
Q1
$365K Buy
+3,799
New +$381K ﹤0.01% 5007
2022
Q2
Sell
-6,294
Closed -$821K 6495
2022
Q1
$821K Buy
+6,294
New +$749K ﹤0.01% 4984

Other funds holding CURE

Goldman Sachs's CURE Position: Q2 2026 in Review

Goldman Sachs opened a new position in Direxion Daily Healthcare Bull 3X ETF (CURE) in Q2 2026: 41,158 shares worth $4.62M. The stake represents ﹤0.01% of the portfolio and ranks #3941 among its holdings. This is a return to the name: Goldman Sachs previously reported a position in CURE as recently as Q3 2023.

Goldman Sachs first reported a position in CURE in Q1 2022 and has held it in 5 quarters since. 19 funds tracked by Wall St. Rank hold CURE as of Q2 2026.

  • Goldman Sachs held 41,158 shares of Direxion Daily Healthcare Bull 3X ETF worth $4.62M as of Q2 2026.
  • Direxion Daily Healthcare Bull 3X ETF was a new Goldman Sachs position in Q2 2026.
  • Direxion Daily Healthcare Bull 3X ETF made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #3941 holding.
  • Goldman Sachs first reported a position in Direxion Daily Healthcare Bull 3X ETF in Q1 2022 and has held it in 5 quarters since.
  • 19 funds tracked by Wall St. Rank held Direxion Daily Healthcare Bull 3X ETF as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.